Medical Scientist-Head Mass Spectrometry
Adelaide Medical School
Faculty of Health and Medical Sciences

University of Western Australia, Biochemistry Lapeyronie
Cardiovascular disease, Inflammation, Oxidative stress, Lipids, Mass spectrometry

Areas of interest:
- Analytical chemistry
- Mass spectrometry
- Lipid metabolism, Nutrition (Omega- 3 Fatty Acids)
- Inflammation, Cardiovascular diseases
- Oxidative stress, antioxidants and biomarkers

Connect With Me

External Profiles


University of Western Australia, Biochemistry Lapeyronie
Cardiovascular disease, Inflammation, Oxidative stress, Lipids, Mass spectrometry

Areas of interest:
- Analytical chemistry
- Mass spectrometry
- Lipid metabolism, Nutrition (Omega- 3 Fatty Acids)
- Inflammation, Cardiovascular diseases
- Oxidative stress, antioxidants and biomarkers


Date Position Institution name
2016 Adjunct Fellow (honorary title) Faculty of Health Science
2015 Medical Scientist Health-SA Pathology

Language Competencies

Language Competency
French Can read, write, speak, understand spoken and peer review


Date Institution name Country Title
University of Montpellier I, Faculty of Pharmacy France PharmD (Doctor in Pharmacy)
University of Montpellier I France PhD


Analytical Chemistry, Analytical Spectrometry, Medical Biochemistry: Lipids, Nutrition & Dietetics


Date Citation
2017 Silbert,B, Ho,K, Lipman,J, Roberts,J, Corcoran,T, Morgan,D, Pavey,W, Mas,E, Barden,A, Mori,T et al, 2017, Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?, Antioxid Redox Signal, 26, 5, 221-226 10.1089/ars.2016.6845
2016 See,V, Mas,E, Burrows,S, O'Callaghan,N, Fenech,M, Prescott,S, Beilin,L, Huang,R, Mori,T, 2016, Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial, Prostaglandins Leukotrienes and Essential Fatty Acids, 112, 50-55 10.1016/j.plefa.2016.08.006
2016 Bondonno,N, Bondonno,C, Rich,L, Mas,E, Shinde,S, Ward,N, Hodgson,J, Croft,K, 2016, Acute effects of quercetin-3-O-glucoside on endothelial function and blood pressure: A randomized dose-response study, American Journal of Clinical Nutrition, 104, 1, 97-103 10.3945/ajcn.116.131268
2016 Barden,A, O Callaghan,N, Burke,V, Mas,E, Beilin,L, Fenech,M, Irish,A, Watts,G, Puddey,I, Huang,R et al, 2016, n-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease, Nutrients, 8, 3, 1-11 10.3390/nu8030175
2016 Barden,A, Mas,E, Mori,T, 2016, n-3 Fatty acid supplementation and proresolving mediators of inflammation, Current Opinion in Lipidology, 27, 1, 26-32 10.1097/MOL.0000000000000262
2016 Jiang,R, Hodgson,J, Mas,E, Croft,K, Ward,N, 2016, Chlorogenic acid improves ex vivo vessel function and protects endothelial cells against HOCl-induced oxidative damage, via increased production of nitric oxide and induction of Hmox-1, Journal of Nutritional Biochemistry, 27, 53-60 10.1016/j.jnutbio.2015.08.017
2016 Corcoran,T, Mas,E, Barden,A, Roberts,L, Mori,T, O'Loughlin,E, 2016, Controlled moderate hypovolaemia in healthy volunteers is not associated with the development of oxidative stress assessed by plasma F2-isoprostanes and isofurans, Prostaglandins and Other Lipid Mediators, 124, 34-38 10.1016/j.prostaglandins.2016.07.001
2016 Barden,A, Moghaddami,M, Mas,E, Phillips,M, Cleland,L, Mori,T, 2016, Specialised pro-resolving mediators of inflammation in inflammatory arthritis, Prostaglandins Leukotrienes and Essential Fatty Acids, 107, 24-29 10.1016/j.plefa.2016.03.004
2016 Silbert,B, Ho,K, Lipman,J, Roberts,J, Corcoran,T, Morgan,D, Pavey,W, Mas,E, Barden,A, Mori,T et al, 2016, Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study, Critical Care Medicine, 44, 10, e923-e929 10.1097/CCM.0000000000001823
2016 Mas,E, Barden,A, Burke,V, Beilin,L, Watts,G, Huang,R, Puddey,I, Irish,A, Mori,T, 2016, A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease, Clinical Nutrition, 35, 2, 331-336 10.1016/j.clnu.2015.04.004
2015 Keelan,J, Mas,E, D'Vaz,N, Dunstan,J, Li,S, Barden,A, Mark,P, Waddell,B, Prescott,S, Mori,T et al, 2015, Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors, Reproduction, 149, 2, 171-178 10.1530/REP-14-0549
2015 Melody,S, Vincent,R, Mori,T, Mas,E, Barden,A, Waddell,B, Keelan,J, 2015, Effects of omega-3 and omega-6 fatty acids on human placental cytokine production, Placenta, 36, 1, 34-40 10.1016/j.placenta.2014.10.013
2015 Barden,A, Mas,E, Croft,K, Phillips,M, Mori,T, 2015, Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin, American Journal of Clinical Nutrition, 102, 6, 1357-1364 10.3945/ajcn.115.116384
2015 Caillaud,C, Mechta,M, Ainge,H, Madsen,A, Ruell,P, Mas,E, Bisbal,C, Mercier,J, Twigg,S, Mori,T et al, 2015, Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats, Journal of Endocrinology, 225, 2, 77-88 10.1530/JOE-15-0010
2015 Barden,A, Burke,V, Mas,E, Beilin,L, Puddey,I, Watts,G, Irish,A, Mori,T, 2015, N-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease, Journal of Hypertension, 33, 9, 1947-1953 10.1097/HJH.0000000000000621
2014 Barden,A, Mas,E, Croft,K, Phillips,M, Mori,T, 2014, Minimizing artifactual elevation of lipid peroxidation products (F 2-isoprostanes) in plasma during collection and storage, Analytical Biochemistry, 449, 1, 129-131 10.1016/j.ab.2013.12.030
2014 Barden,A, Mas,E, Croft,K, Phillips,M, Mori,T, 2014, Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation, Journal of Lipid Research, 55, 11, 2401-2407 10.1194/jlr.M045583
2013 Ramsden,C, Faurot,K, Zamora,D, Suchindran,C, Macintosh,B, Gaylord,S, Ringel,A, Hibbeln,J, Feldstein,A, Mori,T et al, 2013, Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial, Pain, 154, 11, 2441-2451 10.1016/j.pain.2013.07.028
2013 Galano,J, Mas,E, Barden,A, Mori,T, Signorini,C, De Felice,C, Barrett,A, Opere,C, Pinot,E, Schwedhelm,E et al, 2013, Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans, Prostaglandins and Other Lipid Mediators, 107, 95-102 10.1016/j.prostaglandins.2013.04.003
2013 Jones,M, Mark,P, Keelan,J, Barden,A, Mas,E, Mori,T, Waddell,B, 2013, Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta, Journal of Lipid Research, 54, 8, 2247-2254 10.1194/jlr.M039842
2012 Mas,E, Croft,K, Zahra,P, Barden,A, Mori,T, 2012, Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation, Clinical Chemistry, 58, 10, 1476-1484 10.1373/clinchem.2012.190199
2012 Simar,D, Malatesta,D, Mas,E, Delage,M, Caillaud,C, 2012, Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation, Journal of Nutrition, Health and Aging, 16, 2, 155-161 10.1007/s12603-011-0106-5
2012 Mubarak,A, Bondonno,C, Liu,A, Considine,M, Rich,L, Mas,E, Croft,K, Hodgson,J, 2012, Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: A randomized trial, Journal of Agricultural and Food Chemistry, 60, 36, 9130-9136 10.1021/jf303440j
2012 Barden,A, Corcoran,T, Mas,E, Durand,T, Galano,J, Roberts,L, Paech,M, Muchatuta,N, Phillips,M, Mori,T et al, 2012, Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?, Antioxidants and Redox Signaling, 16, 2, 165-169 10.1089/ars.2011.4214
2012 MacHon,C, Thezenas,S, Dupuy,A, Assenat,E, Michel,F, Mas,E, Senesse,P, Cristol,J, 2012, Immunonutrition before and during radiochemotherapy: Improvement of inflammatory parameters in head and neck cancer patients, Supportive Care in Cancer, 20, 12, 3129-3135 10.1007/s00520-012-1444-5
2011 Corcoran,T, Barden,A, Mas,E, Grape,S, Koren,V, Phillips,M, Roberts,L, Mori,T, 2011, Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery, Free Radical Biology and Medicine, 51, 6, 1235-1239 10.1016/j.freeradbiomed.2011.06.026
2011 Corcoran,T, Mas,E, Barden,A, Durand,T, Galano,J, Roberts,L, Phillips,M, Ho,K, Mori,T, 2011, Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?, Antioxidants and Redox Signaling, 15, 10, 2663-2667 10.1089/ars.2011.4125
2011 Mas,E, Barden,A, Corcoran,T, Phillips,M, Roberts,L, Mori,T, 2011, Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery, Free Radical Biology and Medicine, 50, 9, 1171-1176 10.1016/j.freeradbiomed.2011.01.021
2011 Barden,A, Mas,E, Henry,P, Durand,T, Galano,J, Roberts,L, Croft,K, Mori,T, 2011, The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function, Free Radical Research, 45, 4, 469-476 10.3109/10715762.2010.544730
2010 Mas,E, Mori,T, 2010, Coenzyme Q10 and statin myalgia: What is the evidence?, Current Atherosclerosis Reports, 12, 6, 407-413 10.1007/s11883-010-0134-3
2010 Mas,E, Woodman,R, Burke,V, Puddey,I, Beilin,L, Durand,T, Mori,T, 2010, The omega-3 fatty acids EPA and DHA decrease plasma F2- isoprostanes: Results from two placebo-controlled interventions, Free Radical Research, 44, 9, 983-990 10.3109/10715762.2010.492830
2010 Mas,E, Barden,A, Durand,T, Galano,J, Croft,K, Mori,T, 2010, Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances, Free Radical Research, 44, 2, 191-198 10.3109/10715760903390838
2010 Yan,Z, Mas,E, Mori,T, Croft,K, Barden,A, 2010, A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates, Analytical Biochemistry, 403, 1-2, 126-128 10.1016/j.ab.2010.04.016
2010 Monnier,L, Colette,C, Mas,E, Michel,F, Cristol,J, Boegner,C, Owens,D, 2010, Regulation of oxidative stress by glycaemic control: Evidence for an independent inhibitory effect of insulin therapy, Diabetologia, 53, 3, 562-571 10.1007/s00125-009-1574-6
2010 Chevassus,H, Gaillard,J, Farret,A, Costa,F, Gabillaud,I, Mas,E, Dupuy,A, Michel,F, Cantié,C, Renard,E et al, 2010, A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects, European Journal of Clinical Pharmacology, 66, 5, 449-455 10.1007/s00228-009-0770-0
2009 Dauvilliers,Y, Abril,B, Mas,E, Michel,F, Tafti,M, 2009, Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment, Neurology, 73, 16, 1333-1334 10.1212/WNL.0b013e3181bd1344
2008 Michel,F, Bonnefont-Rousselot,D, Mas,E, Drai,J, Thérond,P, 2008, Biomarkers of lipid peroxidation: Analytical aspects, Annales de Biologie Clinique, 66, 6, 605-620 10.1684/abc.2008.0283
2008 Mas,E, Michel,F, Guy,A, Bultel,V, Falquet,Y, Chardon,P, Rossi,J, Cristol,J, Durand,T, 2008, Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry. Application to polytraumatized patients, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 872, 1-2, 133-140 10.1016/j.jchromb.2008.07.037
2008 Delample,D, Durand,F, Severac,A, Belghith,M, Mas,E, Michel,F, Cristol,J, Hayot,M, Prefaut,C, 2008, Implication of xanthine oxidase in muscle oxidative stress in COPD patients, Free Radical Research, 42, 9, 807-814 10.1080/10715760802429039
2006 Monnier,L, Mas,E, Ginet,C, Michel,F, Villon,L, Cristol,JP, Colette,C, 2006, Glucose fluctuations and oxidative stress - Reply, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 296, 14, 1730-1731 10.1001/jama.296.14.1730-b
2006 Monnier,L, Mas,E, Ginet,C, Michel,F, Villon,L, Cristol,J, Colette,C, 2006, Compared effects of the acute glycemic fluctuations and the chronic hyperglycemic on the activation of the stress oxidizing in the diabetic patients of type 2, DIABETES & METABOLISM, 32, S19-S19
2006 Mas,E, Dupuy,A, Artero,S, Portet,F, Cristol,J, Ritchie,K, Touchon,J, 2006, Functional vitamin E deficiency in ApoE4 patients with Alzheimer's disease, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 21, 3, 198-204 10.1159/000090868
2006 Monnier,L, Mas,E, Ginet,C, Michel,F, Villon,L, Cristol,J, Colette,C, 2006, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295, 14, 1681-1687 10.1001/jama.295.14.1681
2005 Leger,C, Carbonneau,M, Michel,F, Mas,E, Monnier,L, Cristol,J, Descomps,B, 2005, A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes, EUROPEAN JOURNAL OF CLINICAL NUTRITION, 59, 5, 727-730 10.1038/sj.ejcn.1602133
2002 Cl,L, Leger,C, Visioli,F, Carbonneau,M, Michel,F, Mas,E, Cristol,J, Descomps,B, Monnier,L, 2002, Hydroxytyrosol-enriched olive mill wastewater preparation (HTROW) decreases blood TXB2 and does not change urinary isoprostane production in healthy or diabetic subjects in two parallel intervention studies, FREE RADICAL BIOLOGY AND MEDICINE, 33, S195-S196
2001 Dupuy,A, Mas,E, Ritchie,K, Descomps,B, Badiou,S, Cristol,J, Touchon,J, 2001, The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease, GERONTOLOGY, 47, 4, 213-218 10.1159/000052801

Book Chapters

Date Citation
2010 Mas,E, Cristol,JP, Michel,F, 2010, Biomarkers of lipid peroxidation: Quantification of isoprostanes and other oxidation products by mass spectrometry, pp. 225-246

Conference Papers

Date Citation
2008 Michel,F, Bonnefont-Rousselot,D, Mas,E, Drai,J, Thérond,P, 2008, Markers of oxidative stress: Biomarkers of lipid peroxidation
Medical Scientist-Head Mass Spectrometry
North Terrace
Org Unit
Faculty of Health and Medical Sciences